The effect of angiotensin converting enzyme inhibitor versus angiotensin receptor blocker therapy on endothelial function of diabetic patients without overt cardiovascular disease; a comparative study

被引：0
|
作者：
Symeonides, P.
Vratsista, E.
Triantafyllou, K.
Koulouris, S.
机构：
[1] Evangelismos Med Ctr, Athens, Greece
[2] Nicosia Gen Hosp, Nicosia, Cyprus
来源：
EUROPEAN HEART JOURNAL | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 50 条
  • [21] ANTIPROTEINURIC AND RENOPROTECTIVE EFFECTS OF COMBINATION THERAPY WITH AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND AN ANGIOTENSIN RECEPTOR BLOCKER
    Sadiku, Edita
    Idrizi, Alma
    Gjata, Margarita
    Barbullushi, Myftar
    Hoti, Klit
    Tase, Mihal
    Koroshi, Alketa
    NEPHROLOGY, 2005, 10 : A136 - A136
  • [22] Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure
    Struckman, DR
    Rivey, MP
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (02) : 242 - 248
  • [23] COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy
    Kussmaul, William G., III
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (03) : 237 - 238
  • [24] Therapeutic perspective: starting an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in a diabetic patient
    Jarred, Ghassan
    Kennedy, R. Lee
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2010, 1 (01) : 23 - 28
  • [25] Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker adherence in patients with primary versus secondary diagnosis of heart failure
    Brackbill, Marcia L.
    Bashaw-Keaton, Rebecca
    Sytsma, Christine S.
    AMERICAN JOURNAL OF MANAGED CARE, 2007, 13 (10): : 568 - 570
  • [26] Angiotensin converting enzyme inhibitor and angiotensin receptor blocker use and outcomes in patients with colorectal cancer.
    Tuazon, Sherilyn Alvaran
    King, Gentry Teng
    Cruz, Joanna Paula Pingol Sta
    Koc, Jean B. Ong Kian
    Chae, Young Kwang
    Leighton, John Charles
    Daskalakis, Constantine
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [27] Angiotensin-converting enzyme inhibitor and angiotensin receptor blocker use and outcomes in patients with colorectal cancer
    Tuazon, Sherilyn Alvaran
    King, Gantry Teng
    Cruz, Joanna Sta.
    Chae, Young K.
    Koc, Jean B. Ong Klan
    Hegarty, Sarah
    Leighton, John Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Cough in Pediatric Patients Receiving Angiotensin-Converting Enzyme Inhibitor Therapy or Angiotensin Receptor Blocker Therapy in Randomized Controlled Trials
    Baker-Smith, C. M.
    Benjamin, D. K., Jr.
    Califf, R. M.
    Murphy, M. D.
    Li, J. S.
    Smith, P. B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (06) : 668 - 671
  • [29] Effects of therapy with angiotensin-converting enzyme inhibitor in elderly patients with cardiovascular disease
    Kolasinska-Malkowska, Katarzyna
    Cwynar, Marcin
    ARTERIAL HYPERTENSION, 2008, 12 (01): : 67 - 71
  • [30] Is Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Combination Therapy Better Than Monotherapy and Safe in Patients With CKD?
    Berns, Jeffrey S.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (02) : 192 - 196
12345